In a preclinical setting, lncRNAs have been suggested as potential diagnostic or prognostic biomarkers affecting a variety of tissues including the heart (MALAT1), reproductive system (H19), muscle (linc‐MD1), and several cancer types (MALAT1, H19, MEG3, HOTAIR) (reviewed in 81, 82). The gene discussed is MALAT1; the disease is cancer.